Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant T (English, Institute of Medicine | Board on Health Sciences Policy | Forum on Drug Discovery Development and)

About the Book

To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed with multidrug-resistant tuberculosis (MDR TB)--a disease caused by strains of Mycobacterium tuberculosis (M.tb.) resistant to two primary TB drugs (isoniazid and rifampic…

ISBN: 9780309265959